tirzepatide compound lawsuit Novo Nordisk filed a against Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Lilly seeks to intervene in

Advances and prospects of RNA delivery nanoplatforms for cancer therapy

Results: A total of 104 participants with a diagnosis of T2D were selected, with a mean age of 65 years SD = 7.51 and a mean diabetes duration of 19.23 years SD = 11.98

Jerdan K, Fabi SG

Second, prospective cohorts with complete staging, dosing, duration, and adherence data, integrated with tumor genomics, systemic biomarkers, and patientreported outcomes to dissect mechanisms and identify responsive subgroups, he continued

GLP-1 Costs Without Medicaid Coverage Retail prices for GLP-1 medications in 2026: If Medicaid wont cover your GLP-1: TrumpRx the federal direct-purchase portal launched in 2025